Alexander A. Zukiwski - 02 Dec 2021 Form 4 Insider Report for CASI Pharmaceuticals, Inc.

Role
Chief Medical Officer
Signature
/s/Alexander A. Zukiwski
Issuer symbol
N/A
Transactions as of
02 Dec 2021
Net transactions value
$0
Form type
4
Filing time
06 Dec 2021, 15:12:15 UTC
Next filing
09 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CASI Employee Stock Option (Right to Buy) Award $0 -500,000 -50% $0.000000 500,000 02 Dec 2021 Common Stock 500,000 $0.8700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were granted on December 2, 2021 and vest as follows: 25 percent on each of the first, second, third and fourth anniversaries of the date of grant.